These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38779664)

  • 21. Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells.
    Li J; Cao Q; Tong M
    Sci Rep; 2024 May; 14(1):12044. PubMed ID: 38802480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H
    Front Immunol; 2023; 14():1213947. PubMed ID: 37965307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer.
    Cai Z; Zhou F
    Medicine (Baltimore); 2022 Nov; 101(46):e31127. PubMed ID: 36401385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
    Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
    Front Immunol; 2022; 13():939523. PubMed ID: 36091049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer.
    Zhao Z; Miao Z; Hou Y; Zhong Y; Zhang X; Fang X
    Int Immunopharmacol; 2024 Sep; 139():112691. PubMed ID: 39029230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
    Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
    Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
    Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
    Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
    Zhu S; Zhao Q; Fan Y; Tang C
    BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
    Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
    Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer.
    Tao B; Yi C; Ma Y; Li Y; Zhang B; Geng Y; Chen Z; Ma X; Chen J
    Biochem Genet; 2024 Aug; 62(4):2999-3029. PubMed ID: 38062276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
    Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
    Front Genet; 2022; 13():1039465. PubMed ID: 36338978
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
    Wu B; Tao L; Yang D; Li W; Xu H; He Q
    Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Genetic Signature of Lactate Metabolism-Associated Genes Predicting Clinically Distinctive Features and Tumor Microenvironment in Colorectal Cancer.
    Wang K; Lou Y; Tao Z
    Cancer Control; 2024; 31():10732748241272721. PubMed ID: 39121198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.